Literature DB >> 2674441

Systolic blood pressure: arterial compliance and early wave reflection, and their modification by antihypertensive therapy.

M O'Rourke1.   

Abstract

Arterial stiffness (the inverse of compliance) is the major determinant of left ventricular and central aortic peak systolic pressure. Recent prospective epidemiological studies (MRFIT, Framingham) have confirmed the importance of systolic (rather than diastolic) pressure in the development of cardiac failure and stroke, and in all-cause mortality. Arteries stiffen in hypertension and with increasing age. Arterial stiffening increases systolic pressure by two mechanisms. The first is by causing a higher pressure to be generated at the peak of ventricular ejection (through increase in aortic characteristic impedance), and the second is by causing a secondary rise attributable to early return of wave reflection from peripheral sites (through an increase in arterial pulse wave velocity). ACE inhibitors, and also nitrates, decrease arterial stiffness. They also dilate peripheral conduit arteries; this reduces wave reflection. These drugs thus reduce systolic pressure in central arteries not only by reducing arterial stiffness but also by reducing inappropriately early wave reflection. Quantitatively, the latter action seems to be more important than the former. Neither action is seen with beta-blocking agents. These beneficial actions on central systolic pressure are not always apparent when pressure is measured in a peripheral artery such as the brachial or radial. This is because the reflected wave constitutes the peak of the pressure wave in central arteries but is usually just an undulation on the downstroke of the wave in peripheral arteries. Hence sphygmomanometric recordings underestimate reduction in central systolic pressure and in left ventricular load brought about by ACE inhibitors and by nitrates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674441

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes.

Authors:  J Goodfellow; M W Ramsey; L A Luddington; C J Jones; P A Coates; F Dunstan; M J Lewis; D R Owens; A H Henderson
Journal:  BMJ       Date:  1996-03-23

2.  Noninvasive evaluation of the influence of aortic wave reflection on left ventricular ejection during auxotonic contraction.

Authors:  H Miyashita; U Ikeda; Y Tsuruya; H Sekiguchi; K Shimada; T Yaginuma
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

Review 3.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

4.  Comparison of lisinopril and nitrendipine on the pulsatility index in mild essential arterial hypertension.

Authors:  D Duprez; M De Buyzere; F Brusselmans; A Maas; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

5.  Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers.

Authors:  M J Kool; J J Spek; H A Struyker Boudier; A P Hoeks; R S Reneman; R H van Herwaarden; L M Van Bortel
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

Review 6.  "Smooth Muscle Cell Stiffness Syndrome"-Revisiting the Structural Basis of Arterial Stiffness.

Authors:  Nancy L Sehgel; Stephen F Vatner; Gerald A Meininger
Journal:  Front Physiol       Date:  2015-11-18       Impact factor: 4.566

7.  Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study.

Authors:  Pedro Martínez-Ayala; Guillermo Adrián Alanis-Sánchez; Luz Alicia González-Hernández; Monserrat Álvarez-Zavala; Rodolfo Ismael Cabrera-Silva; Jaime Federico Andrade-Villanueva; Karina Sánchez-Reyes; Moisés Ramos-Solano; Diego Alberto Castañeda-Zaragoza; David Cardona-Müller; Sylvia Totsuka-Sutto; Ernesto Cardona-Muñoz; Carlos G Ramos-Becerra
Journal:  BMC Cardiovasc Disord       Date:  2020-10-07       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.